**Core tip:** Delayed gastric emptying (DGE) frequently occurs following pancreaticoduodenectomy. Review of our institutional database revealed a DGE rate of less than 20% among patients who underwent PD. DGE was associated with increased healthcare utilization in terms of rates of various postoperative complications, length of hospital stay, and need for transitional care upon discharge. Patients with post-operative pancreatic fistula or intra-abdominal abscess formation were at risk for DGE. Anticipating DGE can help individualize care and allocate resources to high-risk patients.

INTRODUCTION
============

Advances in surgery and critical care have decreased postoperative mortality following pancreaticoduodenectomy (PD) to less than 5% in high-volume centers, and, in addition, the management of post-operative morbidity has also improved\[[@B1]-[@B4]\]. However, delayed gastric emptying (DGE) remains one of the most frequent complications following PD, affecting 15%-30% of patients post-operatively\[[@B5]-[@B8]\]. DGE has been associated with increased hospital stay, higher readmission rates, and impaired quality of life\[[@B9],[@B10]\]. Previous studies have suggested various factors that may influence DGE development, including technical approaches to PD (such as classic *vs* pylorus-preserving resection, antecolic *vs* retrocolic reconstruction) and presence of other intra-abdominal complications (such as pancreatic fistula or intra-abdominal abscess formation)\[[@B11]-[@B17]\].

The aims of this study were to examine a patient database and: (1) determine the incidence of DGE; (2) assess potentially associated risk factors for DGE; and (3) examine the impact of DGE on health care utilization. We hypothesized that the rate of DGE would be comparable to those reported in the literature; that other complications, such as postoperative pancreatic fistula (POPF) formation, may increase likelihood of DGE occurrence; and that DGE would be associated with increased use of health care resources.

MATERIALS AND METHODS
=====================

A prospectively-maintained database was queried to identify 276 consecutive patients who underwent PD at a single institution between 2005 and 2013. Data elements were extracted from this prospectively maintained database and charts were retrospectively reviewed to corroborate variables of interest. The 276 patients were classified into two groups: The group of patients who experienced postoperative DGE and the group of patients who did not.

Baseline demographics, clinical characteristics, and outcomes data were obtained from the medical charts and entered into a prospectively maintained database. Specific demographic data included age at time of diagnosis, gender, and race/ethnicity. The presence of co-morbid conditions, such as hypertension, diabetes mellitus, renal insufficiency, chronic pancreatitis, coronary artery disease, chronic obstructive pulmonary disease, and obesity were recorded, as were clinical characteristics such as presenting symptoms and specific laboratory values. The anesthesia reports were reviewed to record the American Society of Anesthesiologists classification score, operative time (deﬁned as the time from incision to application of the ﬁnal wound dressing), the estimated intraoperative blood loss, and intraoperative transfusion data. The operative reports were reviewed to record details of the procedure and intraoperative characteristics of the pancreas, such as texture and pancreatic duct size.

The primary outcome of interest was development of postoperative DGE, which was defined and graded using the International Study Group of Pancreatic Surgery (ISGPS) criteria\[[@B18]\]. With this definition, the severity of DGE was classified into grades based on the number of days nasogastric drainage was required and the number of days until solid oral intake was tolerated (Table [1](#T1){ref-type="table"}). Grades B and C DGE were considered clinically significant.

###### 

Delayed gastric emptying classification based on International Study Group of Pancreatic Surgery definition

  **DGE grade**   **NGT required**                 **Unable to tolerate solids orally by**   **Vomiting/distention**   **Use of prokinetics**
  --------------- -------------------------------- ----------------------------------------- ------------------------- ------------------------
  A               4-7 d or reinsertion \> POD 3    POD 7                                     ±                         ±
  B               8-14 d or reinsertion \> POD 7   POD 14                                    \+                        \+
  C               14 d or reinsertion \> POD 14    POD 21                                    \+                        \+

Adapted from Wente et al\[[@B18]\]. NGT: Nasogastric tube; POD: Post-operative day; DGE: Delayed gastric emptying.

Secondary outcomes of interest included rates of graded 90-d complications, length of hospital stay, reoperations and readmission rates, and need for transitional care upon hospital discharge. Operative mortality was deﬁned as any death within 90 d of surgery. All complications were recorded using specific and standardized definitions. Complications were graded in severity using the Common Terminology Criteria for Adverse Events CTCAE (v4.03) (grade 1-5) unless otherwise specified\[[@B19]\]. Pancreatic fistula was graded using the International Study Group of Pancreatic Fistula (ISGPF) definition\[[@B20]\].

Statistical analysis
--------------------

A descriptive analysis of the overall study cohort was performed. A univariate comparison of demographic, clinical, operative, and pathologic factors was performed between patients with and without DGE using Student *t* test for continuous variables and χ*^2^* test for categorical variables. In addition to the ISGPF definition for fistula, we also applied the fistula risk score (FRS) developed by Callery et al\[[@B21]\] to determine any potential association between the score and clinically significant DGE. The FRS is a ten-point scale that takes into consideration the weighted influence of four variables (soft pancreatic parenchyma, increased intraoperative blood loss, small duct size, and high-risk pathology) and may correlate with clinically relevant POPF development\[[@B21]\]. Multivariate logistic regression was then used to determine independent predictors of DGE in this cohort. Finally, data of the 49 DGE patients were further analyzed to determine duration of DGE, need for nutritional support, length of hospital stay, and discharge to transitional care facilities.

All results were reported with the appropriate summary statistic, measure of dispersion/variance, and measure of statistical significance. *P* values of \< 0.05 were considered statistically significant. The statistical analysis was conducted using the Statistical Package or the Social Sciences, version 21 (SPSS Inc, Chicago, IL).

RESULTS
=======

Of the 276 patients that underwent PD during the study period, 49 (17.8%) developed DGE. Of the 49 patients with DGE, 25 (9.1%) developed grade A, 14 (5.1%) developed grade B, and 10 (3.6%) developed grade C DGE (Figure [1](#F1){ref-type="fig"}). Characteristics of the overall study population and patients with and without DGE are shown in Table [2](#T2){ref-type="table"}.

![Incidence of post-operative delayed gastric emptying following pancreaticoduodenectomy. Among a cohort of 276 patients, 49 (17.8%) developed DGE. Among the 49 patients with DGE, 25 developed grade A DGE (representing 9.1% of the overall cohort of 276 patients), 14 developed grade B (5.1% of the overall cohort), and 10 developed grade C DGE (3.6% of the overall cohort). DGE: Delayed gastric emptying.](WJGS-9-73-g001){#F1}

###### 

Demographic and clinical characteristics of overall study population and patients with or without delayed gastric emptying

                            **Overall (*n* = 276)**   **No DGE group (*n* = 227)**   **DGE group (*n* = 49)**   ***P* values**
  ------------------------- ------------------------- ------------------------------ -------------------------- ----------------
  Age                       63.2 ± 11.92              62.9 ± 11.95                   64.6 ± 11.77               0.348
  Gender                                                                                                        0.339
  Male                      135 (48.9%)               108 (47.6%)                    27 (55.1%)                 
  Female                    141 (51.1%)               119 (52.4%)                    22 (44.9%)                 
  Co-morbid conditions                                                                                          
  HTN                       147 (53.3%)               119 (52.4%)                    28 (57.1%)                 0.568
  COPD                      13 (4.7%)                 11 (4.8%)                      2 (4.1%)                   1
  DM                        67 (24.3%)                58 (25.6%)                     9 (18.4%)                  0.288
  CRI                       8 (2.9%)                  6 (2.6%)                       2 (4.1%)                   0.635
  History of pancreatitis   42 (15.2%)                36 (15.9%)                     6 (12.2%)                  0.557
  History of ETOH use       122 (44.2%)               102 (44.9%)                    20 (40.8%)                 0.702
  History of tobacco use    57 (20.7%)                49 (21.6%)                     8 (16.3%)                  0.390
  BMI (mean ± SD)           26.7 ± 7.1                27.1 ± 7.28                    25.6 ± 6.91                0.226
  Presenting symptoms                                                                                           
  Weight loss               140 (50.7%)               115 (50.7%)                    25 (51.0%)                 0.921
  Anorexia                  29 (10.5%)                24 (10.6%)                     5 (10.2%)                  0.873
  Early satiety             17 (6.2%)                 16 (7.0%)                      1 (2.0%)                   0.323
  Nausea                    83 (30.1%)                74 (32.6%)                     9 (18.4%)                  0.058
  Vomiting                  43 (15.6%)                40 (17.6%)                     3 (6.1%)                   0.048
  Jaundice                  122 (44.2%)               103 (45.4%)                    19 (38.8%)                 0.419
  Preop albumin             4.0 ± 0.60                4.0 ± 0.59                     3.8 ± 0.62                 0.038
  Preop total bilirubin     2.5 ± 4.29                2.7 ± 4.49                     1.8 ± 3.11                 0.139
  Preop hemoglobin          12.8 ± 1.85               12.8 ± 1.87                    12.7 ± 1.76                0.734
  Preop Cr \> 1.2           40 (14.5%)                31 (13.7%)                     9 (18.4%)                  0.378

DGE: Delayed gastric emptying; HTN: Hypertension; COPD: Chronic obstructive pulmonary disease; DM: Diabetes mellitus; CRI: Chronic renal insufficiency; ETOH: Ethanol; BMI: Body mass index; Preop: Pre-operative; Cr: Creatinine.

Patients with DGE had demographic features and clinical characteristics similar to those of patients without DGE. The majority of the patients (*n* = 221, 80.1%) underwent pylorus-preserving PD with antecolic hand-sewn enteric anastomosis (Table [3](#T3){ref-type="table"}). None of the patients received a gastrostomy or jejunostomy tube and all nasogastric drainage tubes were removed in the operating room upon completion of the operation. Patients who developed DGE underwent procedures of comparable duration and had no significantly higher intraoperative blood losses. There was also no difference in the use of anastomotic pancreatic duct stents, the texture of the pancreas, or the distribution of pathological diagnoses in either group. The frequency and severity of complications were increased among patients who experienced DGE. Forty of the 49 patients (81.6%) with DGE presented at least 1 other complication, whereas in the group of patients without DGE, 70% of patients presented no complications at all. Of the 49 patients with DGE, 37 (75.5%) had at least 1 complication greater than grade 2 severity in comparison to only 20.7% of patients in the group without DGE. Post-operatively, pancreatic fistula developed in 64 (23.2%) patients. Patients with DGE were more likely to experience clinically significant POPF than those without DGE (22.4% *vs* 6.2% grade B-C POPF, *P* \< 0.001). Patients with DGE were also more likely to have intra-abdominal abscess (16.3% *vs* 4.0%, *P* = 0.012) (Table [4](#T4){ref-type="table"}).

###### 

Operative and pathology details

                           **Overall (*n* = 276)**   **No DGE group (*n* = 227)**   **DGE group (*n* = 49)**   ***P* values**
  ------------------------ ------------------------- ------------------------------ -------------------------- ----------------
  ASA class                                                                                                    0.398
  1                        1 (0.4%)                  1 (0.4%)                       0 (0.0%)                   
  2                        78 (28.3%)                59 (26.0%)                     19 (38.8%)                 
  3                        172 (62.3%)               144 (63.4%)                    28 (57.1%)                 
  4                        16 (5.8%)                 14 (6.2%)                      2 (4.1%)                   
  Operative time           452.1 ± 100.6             450.0 ± 100.87                 461.6 ± 99.7               0.467
  Procedure performed                                                                                          0.169
  Classic                  55 (19.9%)                49 (21.6%)                     6 (12.2%)                  
  Pylorus-preserving       221 (80.1%)               178 (78.4%)                    43 (87.8%)                 
  EBL                      515.7 ± 571.4             509.3 ± 533.59                 544.0 ± 722.99             0.702
  Transfusions             49 (17.8%)                37 (16.3%)                     12 (24.5%)                 0.178
  Pancreas texture                                                                                             0.264
  Soft                     144 (52.2%)               115 (50.7%)                    29 (59.2%)                 
  Firm/hard                121 (64.8%)               103 (45.4%)                    18 (36.7%)                 
  PD size                  4.2 ± 2.29                4.3 ± 2.21                     4.1 ± 2.65                 0.612
  PD anastomotic stent     117 (42.4%)               99 (43.6%)                     18 (36.7%)                 0.377
  Vein resection           41 (14.9%)                34 (15.0%)                     7 (14.3%)                  0.902
  Pathological diagnosis                                                                                       
  PDAC                     118 (42.8%)               103 (45.4%)                    15 (30.6%)                 0.058
  Neuroendocrine           12 (4.3%)                 11 (4.8%)                      1 (2.0%)                   0.383
  Ampullary                38 (13.8%)                30 (13.2%)                     8 (16.3%)                  0.567
  Cystic                   41 (14.9%)                32 (14.1%)                     9 (18.4%)                  0.446
  Pancreatitis             33 (12.0%)                28 (12.3%)                     5 (10.2%)                  0.677
  Cholangiocarcinoma       7 (2.5%)                  5 (2.2%)                       2 (4.1%)                   0.807
  Other                    27 (9.8%)                 18 (7.9%)                      9 (18.4%)                  0.026
  Fistula risk score                                                                                           
  Negative (0 points)      34 (12.4%)                28 (12.4%)                     6 (12.2%)                  0.861
  Low (1-2 points)         62 (22.6%)                58 (25.7%)                     4 (8.2%)                   0.008
  Moderate (3-6 points)    138 (50.2%)               106 (46.9%)                    32 (65.3%)                 0.020
  High (7-10 points)       30 (10.9%)                24 (10.6%)                     6 (12.2%)                  0.741

DGE: Delayed gastric emptying; ASA: American Society of Anesthesiologists; EBL: Estimated blood loss; PD: Pancreatic duct; PDAC: Pancreatic ductal adenocarcinoma.

###### 

Rates of selected graded 90-d complication rates

                                                 **Overall (*n* = 276)**   **No DGE group (*n* = 227)**   **DGE group (*n* = 49)**   ***P* values**
  ---------------------------------------------- ------------------------- ------------------------------ -------------------------- ----------------
  Frequency of other complications (any grade)                                                                                       
  Patients with 0 complications                  157 (56.9%)               157 (69.2%)                    0 (0.0%)                   \< 0.001
  Patients with 1 complication                   51 (18.5%)                42 (18.5%)                     9 (18.4%)                  0.982
  Patients with 2 complications                  42 (15.2%)                18 (7.9%)                      24 (49.0%)                 \< 0.001
  Patients with 3 complications                  11 (4.0%)                 5 (2.2%)                       6 (12.2%)                  0.005
  Patients with 4 complications                  8 (2.9%)                  5 (2.2%)                       3 (6.1%)                   0.153
  Patients with ≥ 5 complications                7 (2.5%)                  0 (0.0%)                       7 (14.3%)                  \< 0.001
  Severity of complications                                                                                                          
  Patients with any complication ≥ Grade 3       60 (21.7%)                38 (16.7%)                     22 (44.9%)                 \< 0.001
  Patients with any complication ≥ Grade 2       84 (30.4%)                47 (20.7%)                     37 (75.5%)                 \< 0.001
  Patients with any complication ≥ Grade 1       119 (43.1%)               70 (30.8%)                     49 (100.0%)                \< 0.001
  90-d mortality                                 6 (2.2%)                  4 (1.8%)                       2 (4.1%)                   0.289
  Re-operations                                  12 (4.3%)                 10 (4.4%)                      2 (4.1%)                   1
  Readmissions                                   40 (14.5%)                33 (14.5%)                     7 (14.3%)                  1
  Pancreatic fistula                             64 (23.2%)                43 (18.9%)                     21 (42.9%)                 0.001
  Grade A                                        39 (14.1%)                29 (12.8%)                     10 (20.4%)                 
  Grade B                                        19 (6.9%)                 11 (4.8%)                      8 (16.3%)                  
  Grade C                                        6 (2.2%)                  3 (1.3%)                       3 (6.1%)                   
  Bile leak                                      4 (1.4%)                  1 (0.4%)                       3 (6.1%)                   0.019
  Wound infection                                20 (7.2%)                 12 (5.3%)                      8 (16.3%)                  0.013
  Wound dehiscence                               3 (1.1%)                  1 (0.4%)                       2 (4.1%)                   0.082
  Intra-abdominal abscess                        17 (6.2%)                 9 (4.0%)                       8 (16.3%)                  0.012
  Line infection                                 2 (0.7%)                  2 (0.9%)                       0 (0.0%)                   0.033
  Clostridium difficile                          4 (1.4%)                  1 (0.4%)                       3 (6.1%)                   0.019
  Benign fluid collection                        5 (1.8%)                  2 (0.9%)                       3 (6.1%)                   0.041
  Pneumonia                                      9 (3.3%)                  5 (2.2%)                       4 (8.2%)                   0.056
  Urinary tract infection                        10 (3.6%)                 5 (2.2%)                       5 (10.2%)                  0.018
  Respiratory failure                            9 (3.3%)                  3 (1.3%)                       6 (12.2%)                  0.001
  Encephalopathy                                 5 (1.8%)                  1 (0.4%)                       4 (8.2%)                   0.004
  Arrhythmia                                     16 (5.8%)                 6 (2.6%)                       10 (20.4%)                 \< 0.001
  MI                                             4 (1.4%)                  3 (1.3%)                       1 (2.0%)                   0.545
  DVT                                            2 (0.7%)                  2 (0.9%)                       0 (0%)                     1
  PE                                             2 (0.7%)                  2 (0.9%)                       0 (0%)                     1
  Hemorrhage                                     4 (1.4%)                  3 (1.3%)                       1 (2.0%)                   0.545
  Renal failure                                  5 (1.8%)                  3 (1.3%)                       2 (4.1%)                   0.216
  Hepatic failure                                1 (0.4%)                  0 (0.0%)                       1 (2.0%)                   0.182
  SMV/PV Thrombosis                              8 (2.9%)                  6 (2.6%)                       2 (4.1%)                   0.635

DGE: Delayed gastric emptying; MI: Myocardial infarction; DVT: Deep venous thrombosis; PE: Pulmonary embolism; SMV/PV: Superior mesenteric vein, portal vein.

DGE lasted 8.7 d on average. However, many of the patients in the cohort had grade 1 DGE and, when excluded, the average duration of clinically significant grade B-C DGE was 14.5 d. A nasogastric tube was inserted in 14 of 24 patients (58.3%) with grade B-C DGE and managed with TPN in 69.8% of patients. Patients with DGE had a longer hospital stay (median, 12 d *vs* 7 d, *P* \< 0.001) and were more likely to be discharged to transitional care facilities (24.5% *vs* 6.6%, *P* \< 0.001) (Figure [2](#F2){ref-type="fig"}). They were equally likely to require reoperations or readmissions. Analysis of the FRS showed that 77.5% of patients with DGE had moderate or high scores (*vs* 57.5% of patients without DGE who had moderate or high scores). On multivariate analysis, patients with clinically significant post-operative pancreatic fistula formation and intra-abdominal abscess formation had a higher likelihood of having delayed gastric emptying (Table [5](#T5){ref-type="table"}).

![Health care utilization associated with delayed gastric emptying. Patients with DGE had a longer hospital stay (median 12 d *vs* 7 d, *P* \< 0.001) and were more likely to be discharged to transitional care facilities (24.5% *vs* 6.6%, *P* \< 0.001). DGE: Delayed gastric emptying.](WJGS-9-73-g002){#F2}

###### 

Multivariate analysis of the characteristics of patients with Pancreaticoduodenectomy

                            **Odds ratio (95%CI)**   ***P* value**
  ------------------------- ------------------------ ---------------
  Pancreatic fistula        3.39 (1.35-8.52)         0.009
  Intra-abdominal abscess   1.51 (1.03-2.22)         0.035
  PDAC diagnosis            1.01 (0.524-1.94)        0.982
  Moderate/high FRS         0.99 (0.98-1.01)         0.463

PDAC: Pancreatic ductal adenocarcinoma; FRS: Fistula risk score.

DISCUSSION
==========

Delayed gastric emptying is one of the most common complications following PD, but it remains difficult to predict. Previous studies have suggested various factors associated with DGE development, such as technical approaches to pancreatectomy (classic *vs* pylorus-preserving resection or antecolic *vs* retrocolic reconstruction), and presence of other intra-abdominal complications such as pancreatic fistula or intraabdominal abscess formation\[[@B11]-[@B17]\]. In this series, we found a DGE rate of less than 20%; an association of DGE with a higher rate of post-operative complications, particularly post-operative pancreatic fistula formation; and significantly increased healthcare utilization, including longer length of hospital stay and greater need for transitional care upon discharge.

Most of our patients (*n* = 221, 80.1%) underwent pylorus-preserving PD without intraoperative placement of nasojejunal, gastrostomy, or jejunostomy tubes. All nasogastric tubes were removed in the operating room upon completion of the operation. Reinsertion of a nasogastric tube for gastric decompression, or inability to tolerate oral intake, or abdominal distention, emesis, or need for prokinetic agents thus constituted DGE based on ISGPS criteria (Table [1](#T1){ref-type="table"}). Although our DGE rate was relatively low and consistent with the rates of other reported series, it was associated with other complications and lengthier hospital stay, and this raised the question of whether specific interventions, such as prophylactic placement of enteric tubes, may be worthwhile to mitigate potential consequences of DGE.

Mack et al\[[@B22]\] conducted a randomized study between 1999 and 2002 to assess the feasibility and safety of prophylactically placing double-lumen gastrojejunostomy tubes in patients undergoing PD. They found that insertion of a gastrojejunostomy tube was safe and decreased the incidence of DGE, length of hospital stay, and hospital costs\[[@B22]\]. They viewed the insertion of the gastrojejunostomy tube as an adjunctive measure for providing gastric decompression without the need for a nasogastric tube or its associated risk for respiratory discomforts, and also as a means of providing enteral nutrition, should it be needed. No larger trials have been conducted to confirm Mack et al's\[[@B22]\] findings or to determine the effect of similar interventions on long-term quality of life, nutritional outcomes, or receipt of oncologic care, such as time to initiation of adjuvant therapy. Widespread adoption of this approach in the perioperative setting would, however, expose the majority of patients to tubes they may not need postoperatively, as well as to associated complications, such as tube dislodgments, leaks, infections, aspiration, and peritonitis\[[@B23]\].

In our study, a nasogastric tube was inserted postoperatively for gastric decompression in 14 of 24 patients (58.3%) with grade B or C DGE. We did not observe any complications with placement of a nasogastric tube in the early postoperative period. If grade B or C DGE persisted, patients were either supported with TPN and/or a nasojejunal feeding tube for enteral feeding was placed by an interventional radiologist. We did not use endoscopically placed gastrostomy or combined gastrostomy-jejunal tubes. Although we did not perform any cost estimate analysis of parenteral *vs* enteral feeding in this cohort, it is well established that enteral nutrition is less costly than TPN\[[@B24],[@B25]\]. Data from Mack et al\[[@B22]\], as well as cost-analysis modeling\[[@B26]\], demonstrated that costs for patients treated with a gastrojejunostomy tube were less than those for patients treated without a gastrojejunostomy, even though 100% of patients in the gastrojejunostomy group received nutritional supplementation compared with only 20% to 40% of the patients in the group treated by more standard methods\[[@B22],[@B26]\].

In an era focused on increasing patient throughput and standardizing postoperative care plans, identifying patients who may deviate from the expected postoperative course and implementing strategies to curtail downstream effects is important. Placing enteral tubes in all patients undergoing PD would certainly result in significant over-treatment and risk complications associated with the tube. However, placement in patients at higher risk for developing DGE could potentially facilitate an earlier discharge, improve patient comfort, and decrease health care costs.

Our multivariate analysis showed that patients with pancreatic fistula or intra-abdominal abscess formation had a significantly higher likelihood of developing DGE. This correlation is consistent with those found in other published series\[[@B27],[@B28]\]. In a large multi-institutional study of the American College of Surgeons National Surgical Quality Improvement Program Pancreatectomy Demonstration Project, only pancreatic fistula, postoperative sepsis, and reoperation were independently associated with DGE in 711 patients undergoing PD or total pancreatectomy\[[@B27]\].

Although the majority of patients with DGE in this study also had other postoperative complications, we did identify 9 patients with isolated DGE. These patients were no different than patients without DGE with regards to clinical features or operative factors. Five of these 9 cases of DGE were clinically insignificant and lasted between 4 to 6 d. Although our DGE rate in this series is around 20%, which is consistent with those reported in the literature, this rate captures patients with even clinically-insignificant episodes of DGE as well as those patients who required insertion of nasogastric tube for reasons that may not have been related to DGE, such as prolonged intubation secondary to pneumonia. These patients, however, represent a very small subset of patients with DGE.

The DGE rate in this series is lower than most other institutional experiences reported in the literature, such as the series by Welsch et al\[[@B29]\] in which a DGE rate of 44.5% was recorded. While most operative features, such as rate of vascular reconstruction, operative time, estimated blood loss, and patient co-morbidities appear similar to our series, we believe the low rate in this series is due largely to the uniformity of surgical approach within our cohort. All cases were performed by a single surgeon in a consistent manner utilizing a pylorus preserving pancreaticoduodenectomy with hand-sewn antecolic enteric anastomoses. While we cannot conclude that any one particular technique leads to lower rates of DGE, this series does demonstrate that consistency and experience over time with a specific method can allow it to be safely performed with acceptable outcomes.

Because of the association between pancreatic fistula and intra-abdominal abscess formation with DGE in this series as well as others, efforts to reduce morbidity of these common post-operative complications should continue. If patients identified as higher risk for POPF or abscess formation are the same ones identified as higher risk for DGE development, perhaps these patients may benefit from specific treatment approaches, such as prophylactic intraoperative placement of nasojejunal tubes or gastrojejunostomy tubes. Anticipating DGE in patients may also allow providers to plan for potential delays in recovery, individualize patient care, and improve allocation of resources (such as transitional care) to high-risk patients. We applied the FRS to our study population in order to determine whether a higher score correlated with increased risk of DGE. While on univariate analysis, a moderate to high FRS correlated with development of DGE, on multivariate analysis, a moderate-high FRS did not predict greater likelihood of DGE development postoperatively. However, the authors believe that further evaluation of the FRS in larger studies or in a prospective manner is warranted to truly determine if this score can aid in identifying patients with DGE.

Limitations of the current study include its retrospective nature and a relatively small cohort of patients with DGE. Strengths of this study include the homogeneity of the study population and the perioperative care. The patients were all operated on in a largely uniform manner (pylorus-preserving resection, antecolic reconstruction) and treated similarly post-operatively (no nasogastric decompression tubes, standardized postoperative care plans, *etc*.). Furthermore, no patients were excluded from this study and detailed post-operative data up to at least 90 d post-operatively is available for each of our patients. In this homogenous population, we identified the presence of postoperative fistula as the only predictor for DGE. Furthermore, w were able to demonstrate an association between moderate/high FRS and clinically significant DGE, suggesting a potential role of this score in predicting clinically significant DGE as well as POPF formation.

In summary, although DGE occurred in less than 20% of patients undergoing PD, it was associated with significantly higher complication rates, longer hospital stay, and increased healthcare utilization postoperatively. Patients with a high risk for pancreatic fistula or intra-abdominal abscess formation are at higher risk for developing DGE. Anticipating DGE in patients following PD is important and may allow providers to plan for potential delays in recovery, individualize patient care, and improve allocation of resources to high-risk patients.
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